Venous Thromboembolism in Patients with Human Immunodeficiency Virus.

TH Open

Thrombosis Service, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Published: July 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368489PMC
http://dx.doi.org/10.1055/a-2110-5884DOI Listing

Publication Analysis

Top Keywords

venous thromboembolism
4
thromboembolism patients
4
patients human
4
human immunodeficiency
4
immunodeficiency virus
4
venous
1
patients
1
human
1
immunodeficiency
1
virus
1

Similar Publications

Variations in Perioperative Thromboprophylaxis Practices: Do the Guidelines Need a Closer Look?

Ann Thorac Surg Short Rep

September 2024

Division of Thoracic Surgery, Department of Surgery, Hackensack Meridian Health Network, Hackensack, New Jersey.

Background: In 2022, the American Association for Thoracic Surgery (AATS) and the European Society of Thoracic Surgeons (ESTS) published joint guidelines regarding the timing, duration, and choice of agent for perioperative venous thromboembolism prophylaxis for thoracic cancer patients. Now, 1 year after their release, we looked to assess practices and general adherence to these recommendations.

Methods: We conducted a survey among board-certified/board-eligible thoracic surgeons in the United States, between July and October 2023.

View Article and Find Full Text PDF

Background: Cardiac surgery patients are at increased risk for venous thromboembolism (VTE). Prevention is the most critical strategy to reduce VTE-associated morbidity and death. However, there is a lack of data on the optimal approach to VTE prophylaxis in this population of high-risk patients.

View Article and Find Full Text PDF

Anticoagulation in Patients With Cancer.

JACC Case Rep

November 2024

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article and Find Full Text PDF

Hematologic Complications of Pregnancy.

Eur J Haematol

January 2025

Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon, USA.

Hematologic complications are common in pregnancy and can significantly impact both maternal and fetal health. Recognizing and treating these complications can be challenging due to the limited evidence available to guide clinical consultants. Iron deficiency anemia is the most prevalent hematologic issue in pregnancy and often occurs due to increased maternal blood volume and the nutritional demands of the growing fetus.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!